Multiple sclerosis (MS) is a chronic disease associated with significant patient burden. Early treatment remains crucial to slowing inflammation and delay or prevent disability by reducing the frequency of relapses and MRI lesions. This program reviews the disease burden and discusses different treatment options for patients with MS. The overall goal is to increase clinicians’ confidence in choosing an approach to MS treatment that will optimize patient outcomes.
This learning series is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and is approved by Queens University and accredited by the Saudi Commission for Health Specialties for up to 5.5 CPD hour(s) for the completion of all components within the series.